How the patent system fails to encourage potentially valuable drugs

from The Incidental Economist at on September 30, 2015 at 12:00PM

The following originally appeared on The Upshot (copyright 2015, The New York Times Company). Hillary Rodham Clinton’s prescription drug policy proposal, released last week, would hold drug manufacturers accountable to their level of investment in research. But there are some potentially valuable drugs we’ll never get drug companies to invest in — those that cannot be patented. […]